4.6 Review

Emerging Roles for Polycomb-Group Proteins in Stem Cells and Cancer

Journal

TRENDS IN BIOCHEMICAL SCIENCES
Volume 44, Issue 8, Pages 688-700

Publisher

ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tibs.2019.04.005

Keywords

-

Funding

  1. Sylvester Comprehensive Cancer Center funds
  2. AACR-Bayer Innovation and Discovery grant [18-80-44-MORE]
  3. Flight Attendant Medical Research Institute (FAMRI) Breast Cancer Developmental Grant
  4. ACS-American Cancer Society [IRG-17-183-16]
  5. Leukemia and Lymphoma Society Specialized Center of Research Grant (LLS-SCOR)

Ask authors/readers for more resources

Polycomb-group (PcG) complexes are multiprotein, evolutionarily conserved epigenetic machineries that regulate stem cell fate decisions and development, and are also implicated in cancer and other maladies. The PcG machinery can be divided into two major complexes: Polycomb repressive complex 1 and 2 (PRC1 and PRC2). Traditionally, PcG complexes have been associated with maintenance of gene repression mainly via histone-modifying activities. However, during the last years, increasing evidence indicates that the PcG complexes can also positively regulate gene transcription and modify non-histone substrates in multiple biological processes, cellular stages, and cancers. In this review, we will illustrate recent findings in PcG-mediated gene regulation, with special focus on the recently described non-classical functions of PcG complexes in stem cells and cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available